The annual report, which pulls on QBE’s proprietary claims knowledge, discovered that neoplasms account for 36% of all stop-loss declare reimbursements, sustaining their place because the main analysis throughout all deductible ranges. On the $200,000 deductible stage, neoplasm declare severity rose 12% from the common of prior years, whereas frequency climbed practically 30%. Throughout all circumstances, the frequency of members exceeding $200,000 in annual claims per 10,000 staff elevated by practically 20% 12 months on 12 months, pushed primarily by neoplasms, birth-related claims and circulatory illnesses. Start-related declare frequency greater than doubled between 2024 and 2025.
